shutterstock_1524542537_michael_vi

Michael Vi / Shutterstock.com

9 February 2021AmericasRory O'Neill

J&J reaches $6m settlement over counterfeit surgical tools

Johnson & Johnson (J&J) has settled its case against Advanced Inventory Management (AIM), trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More on this story

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More on this story

article

Report: Market for anti-counterfeit drugs packaging to hit $191bn by 2030

24 January 2023 New study examines industry by product, application and region | China, Germany and India predicted to see the largest growth.

Surgical device maker hit with $10m damages in stapler patent dispute

20 October 2022 Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.

Federal Circuit backs PTAB in Johnson & Johnson patent appeal

4 January 2017 The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB